influenza (flu)

July 24, 2023

Study explores how often children diagnosed with flu experience serious neuropsychiatric side effects

A Vanderbilt study is among the first to quantify how often children diagnosed with flu experience serious neuropsychiatric side effects.

By Jessica Pasley
March 2, 2023

High-dose flu vaccine beneficial for pediatric stem cell transplant patients

Vanderbilt was the lead site for an influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population.

By Jessica Pasley
Computer illustration of a plasma cell (B-cell, left) secreting antibodies (white) against influenza viruses (right). Antibodies bind to specific antigens, for instance viral proteins, marking them for destruction by phagocyte immune cells.
February 2, 2023

Risk of household flu spread skyrocketed during pandemic

A Vanderbilt study found that the household spread of flu during the 2021-2022 season was more than twice as high as it was prior to the COVID-19 pandemic.

By Jake Lowary
December 21, 2022

Flu season came early, hit hard in Tennessee

Flu season came a month early this year in Tennessee and hit hard, disproportionately affecting children, according to Epidemic Intelligence Service (EIS) data gathered by the Centers for Disease Control and Prevention (CDC), Tennessee Department of Health and Vanderbilt University Medical Center.

By Craig Boerner
November 8, 2022

Employee flu vaccine deadline moved forward to Nov. 18

By VUMC News and Communications
LaKeysha Houston, a student pharmacist, gives a flu shot to Lacy Blanton III at last week’s Flulapalooza event on the VUMC campus. Nearly 10,000 faculty, staff, postdoc scholars and students were vaccinated.
October 6, 2022

Flulapalooza

Nearly 10,000 faculty, staff, postdoc scholars and students were vaccinated at last week’s Flulapalooza event.

By VUMC News and Communications
October 5, 2022

Flulapalooza returns to protect thousands from flu

After a two-year pause due to the COVID-19 pandemic, Flulapalooza returned in person and thousands of Vanderbilt employees and students flocked to the daylong event.
By Kelli Mitchuson
August 4, 2022

Study tracks limited use of influenza antiviral therapy

A Vanderbilt study found that more than half of children diagnosed with influenza and deemed high risk for flu-related complications were given the recommended antiviral treatment.
By Jessica Pasley
July 28, 2022

Study to evaluate nasal flu vaccine for children

Pediatricians with the Vanderbilt Vaccine Research Program are looking for healthy infants and children (6 months – 8 years of age) to take part in a nasal influenza vaccine study.
By Craig Boerner
April 7, 2022

Study explores parents’ reluctance to flu, COVID vaccines for children

Vanderbilt research found parents who are reluctant to vaccinate their children against the flu are more than five times as likely to decline the COVID-19 vaccine for their children.
By Jessica Pasley
March 17, 2022

Study compares kidney injury risk for COVID, flu patients

A Vanderbilt study found that renin-angiotensin-aldosterone system (RAASi) inhibitor drugs, which are commonly used to regulate high blood pressure, do not disproportionately increase the risk of acute kidney injury (AKI) in patients with COVID-19 compared to patients hospitalized with influenza.
By Emily Stembridge
February 24, 2022

Study to explore neurologic impact of flu treatment

A Vanderbilt study will explore the neurologic and psychiatric complications of flu and evaluate adverse effects of the antiviral treatment oseltamivir, also known by the brand name Tamiflu.
By Jessica Pasley
January 6, 2022

Grant boosts vaccine effectiveness research

By Nancy Humphrey
1 2 3 4 … 10